Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers Results available

A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age

ClinicalTrials.gov ID: NCT06634797

Public ClinicalTrials.gov record NCT06634797. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Observer-blind, Placebo-controlled, Crossover Study to Assess Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age

Study identification

NCT ID
NCT06634797
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
ModernaTX, Inc.
Industry
Enrollment
1,000 participants

Conditions and interventions

Interventions

  • mRNA-1273.712 Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
12 Years to 30 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2024
Primary completion
Jan 19, 2025
Completion
Jan 19, 2025
Last update posted
Feb 3, 2026

2024 – 2025

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Velocity Clinical Research, Phoenix Phoenix Arizona 85006
Velocity Clinical Research, Huntington Park Huntington Park California 90255
Velocity Clinical Research, San Diego La Mesa California 91942
Velocity Clinical Research, Banning San Bernardino California 82408
Velocity Clinical Research, Washington DC Washington D.C. District of Columbia 20016
Velocity Clinical Research, Savannah Savannah Georgia 31406
Velocity Clinical Research, Boise Meridian Idaho 83642
Velocity Clinical Research, Valparaiso Valparaiso Indiana 46383
Velocity Clinical Research, Covington Covington Louisiana 70433
Velocity Clinical Research, Lafayette Lafayette Louisiana 70508
Velocity Clinical Research, New Orleans New Orleans Louisiana 70119
Velocity Clinical Research, Gulfport Gulfport Mississippi 39503
Velocity Clinical Research, Grand Island Grand Island Nebraska 68803
Velocity Clinical Research, Lincoln Lincoln Nebraska 68510
Velocity Clinical Research, Omaha Omaha Nebraska 68134
Velocity Clinical Research, Albuquerque Albuquerque New Mexico 87107
Velocity Clinical Research, Syracuse East Syracuse New York 13057
Velocity Clinical Research, Durham Durham North Carolina 27701
Velocity Clinical Research, Cleveland Beachwood Ohio 44122
Velocity Clinical Research, Cincinnati, Blue Ash Blue Ash Ohio 45242
Velocity Clinical Research, Cincinnati Cincinnati Ohio 45246
Velocity Clinical Research, Anderson Anderson South Carolina 29621
Velocity Clinical Research, Abilene Abilene Texas 79606
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06634797, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06634797 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →